Jan 31, 2014 by Dan CarrollChevron's Earnings Put a Dent in the DowChevron earnings miss the mark as Microsoft keeps the Dow from bigger losses -- and possibly prepares to announce a new CEO.
Jan 31, 2014 by Dan CarrollWill This Revolutionary Health Stock Roar in 2014?Illumina's stock has exploded over the past year as this company seeks to tap into the huge potential of the gene sequencing market, but are even greater gains to come for investors?
Jan 31, 2014 by Dan Carroll2014's Better Biotech Buy: Biogen Idec, Inc. vs. Amgen, Inc.Big biotech has surged in the past few years, with Biogen and Amgen among the two leaders in this industry. Which stock looks the best for investors in 2014?
Jan 30, 2014 by Dan CarrollThe Dow Rides Visa and Nike to Big GainsStrong GDP growth, combined with a big day from Visa's earnings report, keeps the Dow from following its recent trend of big drops. Meanwhile, Nike and Under Armour face off with a pair of strong stock gains.
Jan 29, 2014 by Dan CarrollDow Dives 160 Points as Boeing's Stock Crashes Despite Stellar EarningsInvestors grow jitters all across the market today, but smart long-term investors shouldn't panic at the market's slide.
Jan 28, 2014 by Dan CarrollPfizer Beats Falling Profit as the Dow Bounces Back From Recent LossesDuPont falls to the bottom of the Dow despite a solid earnings report, but the blue-chip index rises behind Pfizer and climbing consumer confidence
Jan 27, 2014 by Dan CarrollCaterpillar Builds an Earnings Bounce to Lead the Dow Into the GreenMerck and United Technologies join Caterpillar as leading blue-chip gainers on a mixed day for the Dow Jones.
Jan 26, 2014 by Dan Carroll1 Innovative Growth Market on the Verge of CollapseHypertension treatment renal denervation has been a hot topic in the medical device industry, but a recent trial disappointment from Medtronic has companies like Covidien and Boston Scientific backpedaling.
Jan 25, 2014 by Dan CarrollAre Cardiac Device Stocks About to Boom?In the wake of St. Jude Medical's recent earnings release, we check in on what you need to watch at Medtronic and Boston Scientific.
Jan 25, 2014 by Dan CarrollThe 3 Biggest Threats to Japan's Economy in 2014Japan's economy hit the accelerator in 2013 as the Nikkei and top stocks like Toyota soared to huge gains. Will looming challenges jeopardize an encore performance in 2014?
Jan 24, 2014 by Dan CarrollIs Health Care's Hottest Stock a Mirage?Organovo Holdings has exploded for huge gains lately, but should you believe in this surging stock?
Jan 24, 2014 by Dan Carroll2014's Better Buy: Johnson & Johnson vs. Abbott LaboratoriesJohnson & Johnson and Abbott Labs are two of health care's top stocks, but which has the better outlook for the year ahead?
Jan 24, 2014 by Dan CarrollMicrosoft, Procter & Gamble Can't Make a Dent in the Dow's 200-Point PlungeDespite strong earnings-related bounces from Procter & Gamble and Microsoft, the Dow and most blue-chip stocks continue the week's big drop.
Jan 23, 2014 by Dan CarrollWhy Cypress Semiconductor, F5 Networks, and Netflix, Inc. Are Today's 3 Best StocksDespite a lousy day on the S&P 500, Netflix's stock blows away the markets with subscriber growth that fuels a double-digit stock jump.
Jan 23, 2014 by Dan CarrollWhat's Behind the Dow's 200-Point Bloodbath?Despite McDonald's stock overcoming lackluster earnings, unsettling news from China's manufacturing sector has the Dow diving deep into the red.
Jan 22, 2014 by Dan CarrollIBM's Crashing Revenue Keeps the Dow SlidingUnited Technologies and Boeing make the most of the Dow's day, but IBM's fall pushes the blue-chip index into the red.
Jan 21, 2014 by Dan Carroll3 Key Takeaways From Johnson & Johnson's Fourth QuarterWhile Johnson & Johnson's following in Pfizer's strategic footsteps by selling off its diagnostics division last week, this company's pharmaceutical business continues to thrive
Jan 21, 2014 by Dan CarrollTravelers, Johnson & Johnson, and Verizon Sink the Dow Despite Earnings SuccessesStrong member performances in the fourth quarter haven't kept the Dow from falling into the red today, as tech stock IBM prepares to announce its own earnings after the closing bell
Jan 18, 2014 by Dan CarrollCan These 3 Struggling Pharma Giants Bounce Back in 2014?AstraZeneca, Eli Lilly, and GlaxoSmithKline have faced their share of difficulties lately. Is there hope for these three big pharma firms and stocks headed forward?
Jan 17, 2014 by Dan Carroll1 Innovative Health Care Stock on the BrinkEdwards Lifesciences is facing the double danger of disappointing device sales and hefty competition. Can this company stave off Medtronic, Boston Scientific, and other rivals to its Sapien heart valve?
